Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5761/atcs.oa.15-00230 http://scihub22266oqcxt.onion/10.5761/atcs.oa.15-00230 C4981776!4981776!26639937     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=26639937&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ann+Thorac+Cardiovasc+Surg 2016 ; 22 (1): 20-6 Nephropedia Template TP {{tp|p=26639937|t=2016. Chemical Pleurodesis Using Mistletoe Extraction (ABNOVAviscum®Injection) for Malignant Pleural Effusion |pdf=|usr=}}{{26639937}} gab.com Text Chemical Pleurodesis Using Mistletoe Extraction (ABNOVAviscum®Injection) for Malignant Pleural Effusion JO: Ann Thorac Cardiovasc Surg http://www.kidney.de/pget.php?&tw=1&pmid=26639937 #FOAvip Purpose: Malignant pleural effusion (MPE) is common in patients with advanced cancer. Chemical pleurodesis can be considered for MPE that do not respond to chemotherapy, radiotherapy, or therapeutic thoracentesis. However, it is not yet clear which agent is more effective and safer in chemical pleurodesis.Methods: This study was designed as a single arm, multicenter, and open-label phase III clinical trial to evaluate efficacy and safety of chemical pleurodesis using mistletoe extraction (ABNOVAviscum®Injection). References of other agents in chemical pleurodesis were investigated to compare efficacy and safety. Efficacy was evaluated by followed up chest X-ray and changes of clinical symptoms and Karnofsky performance scale. Safety was evaluated by serious adverse event (SAE) and changes of laboratory findings. A follow-up period was 4 weeks after last pleurodesis.Results: Of 62 patients, 49 (79.0%) had complete response, 11 (17.7%) had partial response, and two had no response. Mean response rate was significantly different in this study comparing with reference response rate which was 64% (p <0.0001). There were two SAEs, but all were recovered without sequelas.Conclusion: The results of this study suggest that mistletoe extraction (ABNOVAviscum®Injection) could be an effective and safe agent of chemical pleurodesis in patients with MPE. Twit Text FOAVip Chemical Pleurodesis Using Mistletoe Extraction (ABNOVAviscum®Injection) for Malignant Pleural Effusion ????Ann Thorac Cardiovasc Surg http://www.kidney.de/pget.php?&tw=1&pmid=26639937 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26639937 #FOAvip English Wikipedia <ref>{{Cite pmid|26639937}}</ref> Chemical Pleurodesis Using Mistletoe Extraction (ABNOVAviscum®Injection) for Malignant Pleural Effusion #MMPMID26639937 Cho JS; Na KJ; Lee Y; Kim YD; Ahn HY; Park CR; Kim YC Ann Thorac Cardiovasc Surg 2016[]; 22 (1): 20-6 PMID26639937show ga Purpose: Malignant pleural effusion (MPE) is common in patients with advanced cancer. Chemical pleurodesis can be considered for MPE that do not respond to chemotherapy, radiotherapy, or therapeutic thoracentesis. However, it is not yet clear which agent is more effective and safer in chemical pleurodesis.Methods: This study was designed as a single arm, multicenter, and open-label phase III clinical trial to evaluate efficacy and safety of chemical pleurodesis using mistletoe extraction (ABNOVAviscum®Injection). References of other agents in chemical pleurodesis were investigated to compare efficacy and safety. Efficacy was evaluated by followed up chest X-ray and changes of clinical symptoms and Karnofsky performance scale. Safety was evaluated by serious adverse event (SAE) and changes of laboratory findings. A follow-up period was 4 weeks after last pleurodesis.Results: Of 62 patients, 49 (79.0%) had complete response, 11 (17.7%) had partial response, and two had no response. Mean response rate was significantly different in this study comparing with reference response rate which was 64% (p <0.0001). There were two SAEs, but all were recovered without sequelas.Conclusion: The results of this study suggest that mistletoe extraction (ABNOVAviscum®Injection) could be an effective and safe agent of chemical pleurodesis in patients with MPE. äChemical Pleurodesis Using Mistletoe Extraction (ABNOVAviscum®Injectio(epmc).pdf DeepDyve Pubget Overpricing